Doxycycline as a Potential MMP-1 Inhibitor for the Treatment of Spondylitis Tuberculosis: A Study in Rabbit Model.

Background. Tuberculosis (TB) of the spine is a highly disruptive disease, especially in underdeveloped and developing countries. This condition requires standard TB treatment for 9–18 months, which increases patient risk of drug-resistant TB. Consequently, this raises the concern of adopting additi...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 13
Autores principales: Siregar, Otman, Lelo, Aznan, Rahyussalim, Ahmad Jabir, Ilyas, Syafruddin, Benny, Kurniawati, Tri, Augustinus, Yohanes, Hendra, Mandagi, Tommy, Zufar, Muhammad Luqman Labib, Fathurrahman, Irfan
Formato: diagnostic images pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 1/27/2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=161547200&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 161547200
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 1/27/2023
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        161547200
        161547200
        161547200
        10.1155/2023/7421325
        161547200
      ppf: 1
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Doxycycline as a Potential MMP-1 Inhibitor for the Treatment of Spondylitis Tuberculosis: A Study in Rabbit Model.
      aug:
        au:
          Siregar, Otman
          Lelo, Aznan
          Rahyussalim, Ahmad Jabir
          Ilyas, Syafruddin
          Benny
          Kurniawati, Tri
          Augustinus, Yohanes
          Hendra
          Mandagi, Tommy
          Zufar, Muhammad Luqman Labib
          Fathurrahman, Irfan
        affil: Department of Orthopaedics and Traumatology, Adam Malik General Hospital, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
      sug:
        subj:
          Tuberculosis, Spinal Drug Therapy
          Doxycycline Pharmacodynamics
          Antibiotics, Antitubercular Pharmacodynamics
          Matrix Metalloproteinases Antagonists and Inhibitors
          Spondylitis, Ankylosing
          Animal Studies
          Rabbits
          Drug Resistance, Multiple
          Immunohistochemistry
          Vertebral Body Pathology
          Polymerase Chain Reaction
          Mycobacterium Tuberculosis Analysis
          Matrix Metalloproteinases Drug Effects
          Matrix Metalloproteinases Blood
          Doxycycline Administration and Dosage
      ab: Background. Tuberculosis (TB) of the spine is a highly disruptive disease, especially in underdeveloped and developing countries. This condition requires standard TB treatment for 9–18 months, which increases patient risk of drug-resistant TB. Consequently, this raises the concern of adopting additional therapies to shorten the treatment duration, improve the efficacy of anti-TB drugs, and further decrease damage in the affected tissues and organs. Matrix metalloproteinase- (MMP-) 1 is a key regulator of the destruction of the extracellular matrix and associated proteins and is a new potential target for TB treatment research. In the present study, we investigated the effects of doxycycline as an MMP-1 inhibitor in patients with spondylitis TB. Methods. Seventy-two New Zealand white rabbits with spondylitis TB were divided into 12 different groups based on incubation period (2, 4, 6, and 8 weeks) and doxycycline administration (without, 1 mg/kg body weight (BW), and 5 mg/kg BW). We observed the course of infection through the blood concentration changes and immunohistochemical examination of MMP-1, in addition to BTA staining, culture, polymerase chain reaction (PCR), and histopathological examination. Results. Treatment with once daily 5 mg/kg BW doxycycline significantly improved the blood MMP-1 level (p < 0.05) compared with the placebo and 1 mg/kg BW doxycycline. A significantly reduced ongoing infection and a higher healing rate were demonstrated in rabbits with a higher doxycycline dose through BTA staining, culture, PCR, and histopathology. Various degrees of vertebral endplates, vertebral body, and intervertebral disc destruction were observed in 32 rabbits with positive histopathological findings, in addition to positive inflammatory cell infiltration, characterized by numerous lymphocytes, macrophages, and epithelial cells, as well as abundant granulation tissue and necrotic substances proximal to the inoculated vertebral area. Bone and intervertebral disc destructions were more apparent in the untreated rabbits. Conclusion. Our study demonstrated the potential of doxycycline as an adjunctive treatment in spondylitis TB. However, limitations remain regarding the differences in the pathogenesis and virulence of Mycobacterium tuberculosis between rabbit and human systems, sample size, and the dose-dependent effect of doxycycline. Further studies are needed to address these issues.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N